![]() |
Name |
Alpha-Hederin
|
Molecular Formula | C41H66O12 | |
IUPAC Name* |
(4aS,6aR,6aS,6bR,8aR,9R,10S,12aR)-10-[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
|
|
SMILES |
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2O[C@H]3CC[C@]4([C@H]([C@]3(C)CO)CC[C@@]5([C@@H]4CC=C6[C@]5(CC[C@@]7(C6CC(CC7)(C)C)C(=O)O)C)C)C)O)O)O)O)O
|
|
InChI |
InChI=1S/C41H66O12/c1-21-28(44)30(46)31(47)33(51-21)53-32-29(45)24(43)19-50-34(32)52-27-11-12-37(4)25(38(27,5)20-42)10-13-40(7)26(37)9-8-22-23-18-36(2,3)14-16-41(23,35(48)49)17-15-39(22,40)6/h8,21,23-34,42-47H,9-20H2,1-7H3,(H,48,49)/t21-,23?,24-,25+,26+,27-,28-,29-,30+,31+,32+,33-,34-,37-,38-,39+,40+,41-/m0/s1
|
|
InChIKey |
KEOITPILCOILGM-HYJPIGBRSA-N
|
|
Synonyms |
alpha-Hederin; Sapindoside A; (4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-10-[(2S,3R,4S,5S)-4,5-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
|
|
CAS | NA | |
PubChem CID | 118701055 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 751.0 | ALogp: | 3.6 |
HBD: | 7 | HBA: | 12 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 196.0 | Aromatic Rings: | 7 |
Heavy Atoms: | 53 | QED Weighted: | 0.151 |
Caco-2 Permeability: | -5.552 | MDCK Permeability: | 0.00000818 |
Pgp-inhibitor: | 0.92 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.521 | 20% Bioavailability (F20%): | 0.027 |
30% Bioavailability (F30%): | 0.809 |
Blood-Brain-Barrier Penetration (BBB): | 0.025 | Plasma Protein Binding (PPB): | 89.78% |
Volume Distribution (VD): | 0.443 | Fu: | 8.44% |
CYP1A2-inhibitor: | 0.001 | CYP1A2-substrate: | 0.874 |
CYP2C19-inhibitor: | 0.002 | CYP2C19-substrate: | 0.597 |
CYP2C9-inhibitor: | 0.009 | CYP2C9-substrate: | 0.028 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.076 |
CYP3A4-inhibitor: | 0.108 | CYP3A4-substrate: | 0.045 |
Clearance (CL): | 0.852 | Half-life (T1/2): | 0.528 |
hERG Blockers: | 0.021 | Human Hepatotoxicity (H-HT): | 0.248 |
Drug-inuced Liver Injury (DILI): | 0.013 | AMES Toxicity: | 0.076 |
Rat Oral Acute Toxicity: | 0.066 | Maximum Recommended Daily Dose: | 0.489 |
Skin Sensitization: | 0.042 | Carcinogencity: | 0.038 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
Respiratory Toxicity: | 0.963 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004077 | ![]() |
0.606 | D03MTN | ![]() |
0.510 | ||
ENC002265 | ![]() |
0.436 | D0P2IT | ![]() |
0.498 | ||
ENC001939 | ![]() |
0.424 | D07QQD | ![]() |
0.447 | ||
ENC005544 | ![]() |
0.422 | D04RYU | ![]() |
0.389 | ||
ENC000865 | ![]() |
0.401 | D0AR3J | ![]() |
0.369 | ||
ENC001938 | ![]() |
0.397 | D07ORO | ![]() |
0.361 | ||
ENC002180 | ![]() |
0.370 | D04MRG | ![]() |
0.350 | ||
ENC002246 | ![]() |
0.368 | D0M2QH | ![]() |
0.340 | ||
ENC001894 | ![]() |
0.366 | D09HTS | ![]() |
0.332 | ||
ENC001394 | ![]() |
0.356 | D0P6IK | ![]() |
0.324 |